Pancreatic Cancer Research

ResearcherUniversity of VeronaActive in the last 2 years

Giulio Innamorati

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0123-8777; OpenAlex author ID A5037768686. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. Co-author DOI 10.1002/ijc.70592↗
  2. Early cellular plasticity promotes progression and dissemination in pancreatic adenocarcinoma. Co-author DOI 10.1007/s10555-026-10326-1↗
  3. Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms25126619↗
  4. Circulating tumour DNA: a challenging innovation to develop "precision onco-surgery" in pancreatic adenocarcinoma. Co-author DOI 10.1038/s41416-022-01745-2↗
  5. Gα15 in early onset of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-021-94150-3↗
  6. Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model. Co-author DOI 10.3390/biomedicines9111622↗
  7. Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients. First author DOI 10.1016/j.pan.2017.09.008↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Martin Wilkie · 4 shared papers, 2021–2026 · strength 0.89
  2. Roberto Salvia · 3 shared papers, 2021–2026 · strength 0.65
  3. Giorgio Malpeli · 2 shared papers, 2021–2026 · strength 0.48
  4. Claudio Bassi · 3 shared papers, 2017–2022 · strength 0.32
  5. Christine Worthington · 1 shared paper, 2026 · strength 0.24
  6. Doron Yablecovitch · 1 shared paper, 2026 · strength 0.24
  7. Ido Laish · 1 shared paper, 2026 · strength 0.24
  8. Diane M. Simeone · 1 shared paper, 2026 · strength 0.24
  9. Randall E. Brand · 1 shared paper, 2026 · strength 0.24
  10. George Zogopoulos · 1 shared paper, 2026 · strength 0.24
  11. Jennifer B. Permuth · 1 shared paper, 2026 · strength 0.24
  12. Julie Earl · 1 shared paper, 2026 · strength 0.24
  13. Phil A. Hart · 1 shared paper, 2026 · strength 0.24
  14. Yalda Zolghadri · 1 shared paper, 2024 · strength 0.17
  15. Huocong Huang · 1 shared paper, 2024 · strength 0.17
  16. Raymond J. Macdonald · 1 shared paper, 2024 · strength 0.17
  17. Havish Sairaju Kantheti · 1 shared paper, 2024 · strength 0.17
  18. Rolf A. Brekken · 1 shared paper, 2024 · strength 0.17
  19. Antonio Pea · 1 shared paper, 2022 · strength 0.16
  20. Daniel Pietrasz · 1 shared paper, 2022 · strength 0.16
  21. Francesco Lancellotti · 1 shared paper, 2022 · strength 0.16
  22. Claudio Luchini · 1 shared paper, 2022 · strength 0.16
  23. Salvatore Paiella · 2 shared papers, 2017–2021 · strength 0.16
  24. Giamaica Conti · 1 shared paper, 2021 · strength 0.12
  25. Giulio Fracasso · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.